Genelabs Technologies, Inc. Reports Results for the First Quarter of 2008 and Progress on Operational Priorities
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB), a biopharmaceutical company focused on discovering novel compounds for hepatitis, reported first quarter financial results for 2008. The Company also provided an update on its 2008 operational priorities.